1. Biessels GJ, Nobili F, Teunissen CE, Simo R, Scheltens P (2020) Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective. The Lancet Neurology 19 (8):699-710. doi:10.1016/S1474-4422(20)30139-3
2. Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ (2020) Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. The lancet Diabetes & endocrinology 8 (6):535-545. doi:10.1016/S2213-8587(20)30118-2
3. van Duinkerken E, Ryan CM (2020) Diabetes mellitus in the young and the old: Effects on cognitive functioning across the life span. Neurobiology of disease 134:104608. doi:10.1016/j.nbd.2019.104608
4. Hijazi S, Heistek TS, Scheltens P, Neumann U, Shimshek DR, Mansvelder HD, Smit AB, van Kesteren RE (2020) Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer's disease. Mol Psychiatry 25 (12):3380-3398. doi:10.1038/s41380-019-0483-4
5. Biessels GJ, Reagan LP (2015) Hippocampal insulin resistance and cognitive dysfunction. Nature reviews Neuroscience 16 (11):660-671. doi:10.1038/nrn4019
6. Bae CS, Song J (2017) The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain. International journal of molecular sciences 18 (11). doi:10.3390/ijms18112493
7. Qiu CW, Liu ZY, Zhang FL, Zhang L, Li F, Liu SY, He JY, Xiao ZC (2019) Post-stroke gastrodin treatment ameliorates ischemic injury and increases neurogenesis and restores the Wnt/beta-Catenin signaling in focal cerebral ischemia in mice. Brain research 1712:7-15. doi:10.1016/j.brainres.2019.01.043
8. Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, Xu Y, Zhao Q, Si G (2018) A Review on Central Nervous System Effects of Gastrodin. Front Pharmacol 9:24. doi:10.3389/fphar.2018.00024
9. Deng CK, Mu ZH, Miao YH, Liu YD, Zhou L, Huang YJ, Zhang F, Wang YY, Yang ZH, Qian ZY, Wang X, Guo JZ, Zhang MY, Liao XY, Wan Q, Lu D, Zou YY (2019) Gastrodin Ameliorates Motor Learning Deficits Through Preserving Cerebellar Long-Term Depression Pathways in Diabetic Rats. Front Neurosci 13:1239. doi:10.3389/fnins.2019.01239
10. Zhang F, Deng CK, Huang YJ, Miao YH, Wang YY, Zhang Y, Qian ZY, Zhang WQ, Zhou RD, Lei B, Shen X, Wu XY, Cui G, Song JL, Mu ZH, Zou YY (2020) Early Intervention of Gastrodin Improved Motor Learning in Diabetic Rats Through Ameliorating Vascular Dysfunction. Neurochemical research 45 (8):1769-1780. doi:10.1007/s11064-020-03039-6
11. Wang X, Li S, Ma J, Wang C, Chen A, Xin Z, Zhang J (2019) Effect of Gastrodin on Early Brain Injury and Neurological Outcome After Subarachnoid Hemorrhage in Rats. Neurosci Bull. doi:10.1007/s12264-018-00333-w
12. Wang XP, Ye P, Lv J, Zhou L, Qian ZY, Huang YJ, Mu ZH, Wang X, Liu XJ, Wan Q, Yang ZH, Wang F, Zou YY (2019) Expression Changes of NMDA and AMPA Receptor Subunits in the Hippocampus in rats with Diabetes Induced by Streptozotocin Coupled with Memory Impairment. Neurochemical research. doi:10.1007/s11064-019-02733-4
13. Bagatini PB, Xavier LL, Bertoldi K, Moyses F, Lovatel G, Neves LT, Barbosa S, Saur L, de Senna PN, Souto AA, Siqueira IR, Achaval M (2017) An evaluation of aversive memory and hippocampal oxidative status in streptozotocin-induced diabetic rats treated with resveratrol. Neurosci Lett 636:184-189. doi:10.1016/j.neulet.2016.10.059
14. Kleinridders A, Ferris HA, Cai W, Kahn CR (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63 (7):2232-2243. doi:10.2337/db14-0568
15. Heni M, Kullmann S, Preissl H, Fritsche A, Haring HU (2015) Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 11 (12):701-711. doi:10.1038/nrendo.2015.173
16. Moller LLV, Jaurji M, Kjobsted R, Joseph GA, Madsen AB, Knudsen JR, Lundsgaard AM, Andersen NR, Schjerling P, Jensen TE, Krauss RS, Richter EA, Sylow L (2020) Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle. The Journal of physiology 598 (23):5351-5377. doi:10.1113/JP280294
17. Fadista J, Vikman P, Laakso EO, Mollet IG, Esguerra JL, Taneera J, Storm P, Osmark P, Ladenvall C, Prasad RB, Hansson KB, Finotello F, Uvebrant K, Ofori JK, Di Camillo B, Krus U, Cilio CM, Hansson O, Eliasson L, Rosengren AH, Renstrom E, Wollheim CB, Groop L (2014) Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America 111 (38):13924-13929. doi:10.1073/pnas.1402665111
18. Chiang YT, Jin T (2014) p21-Activated protein kinases and their emerging roles in glucose homeostasis. American journal of physiology Endocrinology and metabolism 306 (7):E707-722. doi:10.1152/ajpendo.00506.2013
19. Dammann K, Khare V, Gasche C (2014) Tracing PAKs from GI inflammation to cancer. Gut 63 (7):1173-1184. doi:10.1136/gutjnl-2014-306768
20. Feng HL, Dang HZ, Fan H, Chen XP, Rao YX, Ren Y, Yang JD, Shi J, Wang PW, Tian JZ (2016) Curcumin ameliorates insulin signalling pathway in brain of Alzheimer's disease transgenic mice. International journal of immunopathology and pharmacology 29 (4):734-741. doi:10.1177/0394632016659494
21. Wang X, Zhao L (2016) Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3beta signaling pathway. Biochemical and biophysical research communications 473 (2):428-434. doi:10.1016/j.bbrc.2016.03.024
22. Kang S, Kim CH, Jung H, Kim E, Song HT, Lee JE (2017) Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. Neuropharmacology 113 (Pt A):467-479. doi:10.1016/j.neuropharm.2016.10.029
23. Yoshino Y, Ishisaka M, Tsujii S, Shimazawa M, Hara H (2015) Glucagon-like peptide-1 protects the murine hippocampus against stressors via Akt and ERK1/2 signaling. Biochemical and biophysical research communications 458 (2):274-279. doi:10.1016/j.bbrc.2015.01.098
24. Koepsell H (2020) Glucose transporters in brain in health and disease. Pflugers Archiv : European journal of physiology 472 (9):1299-1343. doi:10.1007/s00424-020-02441-x
25. Pearson-Leary J, McNay EC (2016) Novel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory. The Journal of neuroscience : the official journal of the Society for Neuroscience 36 (47):11851-11864. doi:10.1523/JNEUROSCI.1700-16.2016
26. Park CR (2001) Cognitive effects of insulin in the central nervous system. Neuroscience and biobehavioral reviews 25 (4):311-323. doi:10.1016/s0149-7634(01)00016-1
27. Varshney P, Dey CS (2016) P21-activated kinase 2 (PAK2) regulates glucose uptake and insulin sensitivity in neuronal cells. Mol Cell Endocrinol 429:50-61. doi:10.1016/j.mce.2016.03.035
28. Ye T, Meng X, Zhai Y, Xie W, Wang R, Sun G, Sun X (2018) Gastrodin Ameliorates Cognitive Dysfunction in Diabetes Rat Model via the Suppression of Endoplasmic Reticulum Stress and NLRP3 Inflammasome Activation. Front Pharmacol 9:1346. doi:10.3389/fphar.2018.01346
29. Qi YH, Zhu R, Wang Q, Li Q, Liu YD, Qian ZY, Yang ZH, Mu ZH, Liu XJ, Zhang MY, Wang X, Liao XY, Wan Q, Lu D, Zou YY (2019) Early intervention with gastrodin reduces striatal neurotoxicity in adult rats with experimentallyinduced diabetes mellitus. Molecular medicine reports 19 (4):3114-3122. doi:10.3892/mmr.2019.9954
30. Shi R, Zheng CB, Wang H, Rao Q, Du T, Bai C, Xiao C, Dai Z, Zhang C, Chen C, Li X, Tian M, Yu X, Ji B, Weng Z, Yang W (2020) Gastrodin Alleviates Vascular Dementia in a 2-VO-Vascular Dementia Rat Model by Altering Amyloid and Tau Levels. Pharmacology 105 (7-8):386-396. doi:10.1159/000504056
31. Bai Y, Mo K, Wang G, Chen W, Zhang W, Guo Y, Sun Z (2021) Intervention of Gastrodin in Type 2 Diabetes Mellitus and Its Mechanism. Front Pharmacol 12:710722. doi:10.3389/fphar.2021.710722
32. Chen J, Huang Y, Hu X, Bian X, Nian S (2021) Gastrodin prevents homocysteine-induced human umbilical vein endothelial cells injury via PI3K/Akt/eNOS and Nrf2/ARE pathway. Journal of cellular and molecular medicine 25 (1):345-357. doi:10.1111/jcmm.16073